REGN2810 alone or in combination with REGN1979 for B-lymphoid malignancies
11 Dec 2017
REGN2810 alone or in combination with REGN1979 for B-lymphoid malignancies
Results of the AML 12 trial
T cell therapy for ALL
Immunosuppressive therapy in myelodysplastic syndrome
The ACE-LY-004 study of acalabrutinib monotherapy for mantle cell lymphoma
Why we are not ready for personalised medicine
Genetically profiling entire populations, starting with Estonia
Hypomethylating agents for relapsed and refractory acute myeloid leukaemia
How does ancestry affect your health?
Neuroblastoma and cell communication networks
Approaches to screening and early detection across Europe
Connecting personalised medicine research in Canada with Europe